Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
News for 22nd Century Group, Inc. (Nasdaq: XXII) centers on its role in tobacco harm reduction, regulatory developments, capital structure actions and the commercialization of its VLN® reduced nicotine cigarette platform. Company announcements frequently highlight progress in expanding VLN® and partner VLN® distribution across additional U.S. states and retail chains, including launches with major convenience store operators and authorizations in a large majority of states.
Investors following XXII news will see updates on VLN® regulatory milestones, such as the original FDA Modified Risk Tobacco Product authorization, the filing of the VLN® MRTP renewal application, and the company’s public support for the FDA’s proposed Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products. Releases also discuss clinical research findings related to very low nicotine content cigarettes, including reductions in daily cigarette consumption and increased quit attempts among smokers using 95% reduced nicotine VLN® products.
Another recurring theme in 22nd Century’s news is financial and corporate developments. The company reports on balance sheet changes such as repayment and termination of senior secured debt, settlement of insurance claims related to prior facility incidents, and the use of non-dilutive cash proceeds as growth capital. News items also cover equity and preferred stock financings, at-the-market offering arrangements, and proposals for reverse stock splits and other shareholder approvals under Nasdaq Listing Rules.
In addition, XXII news includes corporate governance and investor relations events, such as participation in investor conferences, quarterly earnings webcasts, and shareholder letters reviewing strategic progress. For readers tracking the intersection of tobacco regulation, reduced nicotine technology and public company capital markets activity, the XXII news feed provides ongoing context on how 22nd Century is executing its harm reduction-focused strategy.
22nd Century Group (XXII) has signed an agreement with Smoker Friendly to launch reduced nicotine content cigarette products under the Smoker Friendly VLN brand, marking their first VLN partner brand agreement. The partnership includes both Smoker Friendly VLN branded products and 22nd Century's own VLN products in gold and menthol SKUs featuring new VLN branding.
This expansion builds on their existing 10-year customer relationship, following the recent addition of Smoker Friendly Black Label style cigarette. The companies are seeking state approvals and expect to begin shipping in the second quarter of 2025.
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on nicotine control and consumer choice, has announced its upcoming presentation at the Emerging Growth Conference. CEO Larry Firestone will deliver the presentation on February 19, 2025, at 10:50 am Eastern Time.
The presentation will include a company overview followed by a potential Q&A session. Investors can submit questions in advance to Questions@EmergingGrowth.com. The event offers both live attendance through pre-registration and post-event access through archived webcasts available on EmergingGrowth.com and the Emerging Growth YouTube Channel.
22nd Century Group (Nasdaq: XXII) has announced receiving formal written notice from Nasdaq confirming its regained compliance with the exchange's Minimum Bid Price Requirement for continued listing under Rule 5550(a)(2).
CEO Larry Firestone emphasized the importance of maintaining Nasdaq listing standards for stockholders and reaffirmed the company's commitment to creating long-term shareholder value through executing their business plans.
22nd Century Group (NASDAQ: XXII) welcomes FDA's proposed new Tobacco Product Standard that would set a maximum nicotine content of 0.7 mg per gram of tobacco in cigarettes. The company's VLN products, currently available in over 5,000 stores nationwide, are the only FDA-authorized reduced nicotine cigarettes that already comply with this standard.
The FDA projects that by 2100, approximately 48 million youth and young adults would avoid starting smoking due to this regulation. The standard would take effect two years after final approval. VLN cigarettes contain 95% less nicotine than conventional cigarettes, positioning 22nd Century Group advantageously as the only current manufacturer meeting the proposed requirements.
22nd Century Group (NASDAQ: XXII) was featured in a Washington Post article discussing the FDA's proposed policy to mandate reduced nicotine content in cigarettes. The policy, which cleared U.S. Office of Management and Budget review on January 3, 2025, could benefit an estimated 13 million smokers in its first five years.
The company's VLN branded low nicotine cigarettes are the first and only combustible tobacco products with FDA Modified Risk Tobacco Product designation, available in over 5,000 stores nationwide. The products are manufactured using proprietary tobacco strains that can be licensed to other brands, potentially creating a new market category similar to non-alcoholic beverages.
The policy initiative, started in 2017 during the Trump administration, is supported by decades of clinical research using 22nd Century's reduced nicotine content cigarettes, demonstrating that adult smokers can effectively control their smoking habits with these products.
22nd Century Group (NASDAQ: XXII) announces its readiness to support the FDA's proposed tobacco product standard mandating reduced nicotine content in cigarettes. The proposal, which cleared review by the U.S. Office of Management and Budget on January 3, 2025, aims to drastically reduce nicotine levels in cigarettes.
The company's VLN branded low nicotine cigarettes align with this initiative, being the first and only FDA-authorized reduced nicotine content cigarettes in the market. CEO Larry Firestone emphasizes the policy's potential significant impact on public health and smoking harm reduction.
22nd Century Group has been instrumental in research and development supporting this policy, which has progressed across multiple administrations since 2009. The company plans to launch additional reduced nicotine content products under other brand labels and aims to expand the distribution and awareness of low nicotine cigarettes as a distinct market category.
22nd Century Group (XXII) has signed a new five-year license and manufacturing agreement with Smoker Friendly, one of the largest independent cigarette retailers in the United States. The agreement covers 11 existing SF brands currently sold in Smoker Friendly's network and introduces 8 new premium brands targeting the natural segment market.
The partnership builds on a decade-long relationship and includes plans to integrate Smoker Friendly's filtered cigar business and add reduced nicotine content brands complementing XXII's VLN product line. The new premium products will occupy a higher market position compared to lower-tier products.
The agreement provides a framework for future product additions and establishes manufacturing volume for XXII's MSA-compliant facility in North Carolina. The company aims to develop VLN companion brands containing 95% less nicotine, targeting adult smokers seeking to reduce their nicotine consumption.
22nd Century Group (NASDAQ: XXII) announced a 1-for-135 reverse stock split effective December 17, 2024, aimed at regaining compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The company's outstanding common stock will be consolidated to approximately 504,000 shares and will continue trading under the symbol 'XXII' with a new CUSIP number.
CEO Lawrence Firestone highlighted significant operational improvements and balance sheet changes made over the past year. The company is implementing a new VLN strategy including private label brands and projects achieving EBITDA profitability as early as Q1 2025. The company has already regained compliance with Nasdaq's shareholders' equity requirement.
22nd Century Group (XXII) reported Q3 2024 financial results showing a decrease in net revenues to $5.9 million from $7.9 million in Q2 2024. The company reported a gross loss of $0.6 million and increased operating loss to $3.4 million. Net loss expanded to $3.6 million with EPS at $(0.27). Cigarette revenues increased to $4.1 million, while filtered cigars revenue declined to $1.7 million. The company aims to achieve EBITDA breakeven in Q1 2025 and plans to launch additional VLN® SKUs within key customer brand families to expand distribution of reduced nicotine content cigarettes.
22nd Century Group (NASDAQ: XXII), a tobacco products company, will announce its third quarter 2024 results on November 12, 2024. The financial results will be released at 6:00 AM ET, followed by a webcast at 8:00 AM ET. During the webcast, CEO Larry Firestone and CFO Dan Otto will review the financial performance and discuss recent progress. The webcast will be available live and archived on the Company's Investor Relations section at https://ir.xxiicentury.com/events. For access, register at least 15 minutes prior to the start of the webcast.